328 related articles for article (PubMed ID: 21697951)
1. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.
Corona C; Pensalfini A; Frazzini V; Sensi SL
Cell Death Dis; 2011 Jun; 2(6):e176. PubMed ID: 21697951
[TBL] [Abstract][Full Text] [Related]
2. Metal homeostasis in dementia.
Sensi S
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S9. PubMed ID: 26461423
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional roles of zinc in Alzheimer's disease.
Xie Z; Wu H; Zhao J
Neurotoxicology; 2020 Sep; 80():112-123. PubMed ID: 32717200
[TBL] [Abstract][Full Text] [Related]
4. Zinc and its effects on oxidative stress in Alzheimer's disease.
Yuan Y; Niu F; Liu Y; Lu N
Neurol Sci; 2014 Jun; 35(6):923-8. PubMed ID: 24522515
[TBL] [Abstract][Full Text] [Related]
5. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
6. Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.
Takeda A; Tamano H
Expert Opin Ther Targets; 2015; 19(8):1051-8. PubMed ID: 25818846
[TBL] [Abstract][Full Text] [Related]
7. Disruption of brain zinc homeostasis promotes the pathophysiological progress of Alzheimer's disease.
Li LB; Wang ZY
Histol Histopathol; 2016 Jun; 31(6):623-7. PubMed ID: 26883958
[TBL] [Abstract][Full Text] [Related]
8. [New biomarkers and drug targets for diagnosis and therapy of Alzheimer's disease (molecular determinants of zinc-dependent oligomerization of Β-amyloid)].
Kozin SA; Makarov AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):5-9. PubMed ID: 25909782
[TBL] [Abstract][Full Text] [Related]
9. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.
Sensi SL; Rapposelli IG; Frazzini V; Mascetra N
Exp Gerontol; 2008 May; 43(5):488-92. PubMed ID: 18068923
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of element profile changes induced by long-term dietary supplementation of zinc in the brain and cerebellum of 3xTg-AD mice by alternated cool and normal plasma ICP-MS.
Ciavardelli D; Consalvo A; Caldaralo V; Di Vacri ML; Nisi S; Corona C; Frazzini V; Sacchetta P; Urbani A; Di Ilio C; Sensi SL
Metallomics; 2012 Dec; 4(12):1321-32. PubMed ID: 23151739
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
12. Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis.
Cascella R; Cecchi C
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066371
[TBL] [Abstract][Full Text] [Related]
13. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
Guan PP; Cao LL; Wang P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
[TBL] [Abstract][Full Text] [Related]
14. Zinc transporters in Alzheimer's disease.
Xu Y; Xiao G; Liu L; Lang M
Mol Brain; 2019 Dec; 12(1):106. PubMed ID: 31818314
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer's Disease.
Calvo-Rodriguez M; Kharitonova EK; Bacskai BJ
Cells; 2020 Nov; 9(11):. PubMed ID: 33233678
[TBL] [Abstract][Full Text] [Related]
16. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
17. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.
Vilella A; Belletti D; Sauer AK; Hagmeyer S; Sarowar T; Masoni M; Stasiak N; Mulvihill JJE; Ruozi B; Forni F; Vandelli MA; Tosi G; Zoli M; Grabrucker AM
J Trace Elem Med Biol; 2018 Sep; 49():210-221. PubMed ID: 29325805
[TBL] [Abstract][Full Text] [Related]
18. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
Esteras N; Abramov AY
Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
[TBL] [Abstract][Full Text] [Related]
20. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
